Bionutrics becomes SEC reporting company; applies for Nasdaq listing.PHOENIX--(BW HealthWire)--March 26, 1997--Bionutrics, Incorporated (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). :BNRX) today announced that it has become a full reporting company under the Securities Exchange Act of 1934. "This marks a significant milestone in our corporate development," Ronald H. Lane, Bionutrics' Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. said. "Being a full SEC reporting company opens additional avenues of opportunity. It has always been management's goal to provide the company and its shareholders with greater visibility and liquidity for the company's common stock, and being a full reporting company is a step in that direction. In conjunction with becoming a full reporting company, Bionutrics has filed an application for a Nasdaq listing," Mr. Lane said. Bionutrics, Inc. is an emerging biopharmaceutical company, headquartered in Phoenix, Arizona Phoenix /ˈfiːˌnɪks/ (English: Phoenix, Navajo: Hoozdo, lit. "the place is hot", Western Apache: Fiinigis) is the capital and the most populous city of the U.S. , with a focus on discovery, development, manufacturing and marketing of all natural products concerning heart disease and stroke. Bionutrics looks for biologically active compounds occurring in nature with pharmaceutical applications. The company's first commercial product, evolvE(TM), is a patented all natural advanced cardiovascular dietary supplement Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene shown to help lower cholesterol. The evolvE(TM) product launch is underway with distribution to national drug, food, discount and dietary supplement chains expected by May/June of this year. CONTACT: Bionutrics, Inc. Ronald H. Lane, 602/508-0112 or The Investor Relations Investor relations The process by which the corporation communicates with its investors. Company Tom Laughran, 847/564-5610 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion